Cancer treatment increasingly includes genetic analysis as a standard test at cancer centers. Doctors at Memorial Sloan Kettering Cancer Center aim to sequence 10,000 patient tumors a year to develop "basket" trials, in which patients are grouped and treated according to tumor genetics instead of where the tumors are located in the body. Drugmakers are also sequencing tumors in the hunt for targeted therapies.
Genetic testing becomes standard at cancer centers
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||